Recordati Industria Chimica e Farmaceutica - RCDTF Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Recordati Industria Chimica e Farmaceutica in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RCDTF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RCDTF, but not buy additional shares or sell existing shares.
View RCDTF analyst ratings or view top-rated stocks.

4 brokerages have issued 1-year price objectives for Recordati Industria Chimica e Farmaceutica's shares. Their RCDTF share price forecasts range from $42.00 to $44.00. On average, they predict the company's share price to reach $43.00 in the next twelve months. This suggests that the stock has a possible downside of 3.3%.
View analysts price targets for RCDTF or view top-rated stocks among Wall Street analysts.

Recordati Industria Chimica e Farmaceutica's stock was trading at $63.9637 at the beginning of the year. Since then, RCDTF shares have decreased by 30.5% and is now trading at $44.4807.
View the best growth stocks for 2022 here.

Recordati Industria Chimica e Farmaceutica saw a increase in short interest in July. As of July 15th, there was short interest totaling 432,200 shares, an increase of 33.4% from the June 30th total of 324,000 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 4,322.0 days.
View Recordati Industria Chimica e Farmaceutica's Short Interest.

Recordati Industria Chimica e Farmaceutica trades on the OTCMKTS under the ticker symbol "RCDTF."

Shares of RCDTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RCDTF stock can currently be purchased for approximately $44.48.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a market capitalization of $9.18 billion and generates $1.87 billion in revenue each year. The company earns $456.64 million in net income (profit) each year or $2.21 on an earnings per share basis.

The company employs 4,303 workers across the globe.

Recordati Industria Chimica e Farmaceutica's mailing address is Via Matteo Civitali 1, Milano L6, 20148. The official website for the company is www.recordati.com. The company can be reached via phone at 390-248-7871, via email at investorelations@recordati.it, or via fax at 39-02-4007-3747.